U.S. Amniotic Membrane Market Size & Outlook, 2022-2030
U.S. amniotic membrane market, 2018-2030 (US$M)
Related Markets
U.S. amniotic membrane market highlights
- The U.S. amniotic membrane market generated a revenue of USD 892.7 million in 2022 and is expected to reach USD 2,208.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 12% from 2023 to 2030.
- In terms of segment, cryopreserved amniotic membrane was the largest revenue generating product in 2022.
- Cryopreserved Amniotic Membrane is the most lucrative product segment registering the fastest growth during the forecast period.
Amniotic membrane market data book summary
| Market revenue in 2022 | USD 892.7 million |
| Market revenue in 2030 | USD 2,208.0 million |
| Growth rate | 12% (CAGR from 2022 to 2030) |
| Largest segment | Cryopreserved amniotic membrane |
| Fastest growing segment | Cryopreserved Amniotic Membrane |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cryopreserved Amniotic Membrane, Dehydrated Amniotic Membrane |
| Key market players worldwide | MiMedx Group Inc, Alliqua BioMedical, Amnio Technology, Human Regenerative Technologies, Integra Lifesciences Holdings Corp, Corza Health, Skye Biologics, Organogenesis Holdings Inc Class A |
Other key industry trends
- In terms of revenue, U.S. accounted for 27.6% of the global amniotic membrane market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. amniotic membrane market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 350.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Amniotic Membrane Market Scope
Amniotic Membrane Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. amniotic membrane market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to amniotic membrane market will help companies and investors design strategic landscapes.
Cryopreserved amniotic membrane was the largest segment with a revenue share of 60.3% in 2022. Horizon Databook has segmented the U.S. amniotic membrane market based on cryopreserved amniotic membrane, dehydrated amniotic membrane covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for the largest market in the North America amniotic membrane market. The U.S. dominated the overall North American market in terms of revenue share in 2021 with 86.9% share.
As per 2011–2015 World Bank Health Expenditure, the U.S. spends nearly 17.1% of its GDP on healthcare.
Increasing prevalence of venous ulcers, pelvic ulcers, and surgical wounds in this region is a key factor expected to drive the market over the forecast period.
Reasons to subscribe to U.S. amniotic membrane market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. amniotic membrane market databook
-
Our clientele includes a mix of amniotic membrane market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. amniotic membrane market , including forecasts for subscribers. This country databook contains high-level insights into U.S. amniotic membrane market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. amniotic membrane market size, by product, 2018-2030 (US$M)
U.S. Amniotic Membrane Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
